>>/173185/,  >>/173186/,  >>/173187/,  >>/173188/,  >>/173189/,  >>/173190/,  >>/173191/,  >>/173192/,  >>/173193/,  >>/173194/,  >>/173195/,  >>/173196/,  >>/173197/,  >>/173198/,  >>/173199/,  >>/173200/,  >>/173201/,  >>/173202/,  >>/173203/,  >>/173204/,  >>/173205/,  >>/173206/,  >>/173207/,  >>/173208/,  >>/173209/,  >>/173210/,  >>/173211/,  >>/173212/,  >>/173213/,  >>/173214/,  >>/173215/,  >>/173216/,  >>/173217/,  >>/173218/,  >>/173219/,  >>/173220/,  >>/173221/,  >>/173222/,  >>/173223/,  >>/173224/,  >>/173225/,  >>/173226/,  >>/173227/,  >>/173228/,  >>/173229/,  >>/173230/,  >>/173231/,  >>/173232/,  >>/173233/,  >>/173234/,  >>/173235/
White House Press Pool Reports @WHPressPool - In-town pool report #2 end of briefing
The briefing began at 11:21 and concluded at 12:25.
The breakdown:
11:21 11:26 Karoline Leavitt on dietary guidelines
11:26 11:33 RFK Jr. on dietary guidelines
11:33 11:39 Ag Sec Rollins
11:39 11:42 Dr. Oz
11:42 11:45 FDA Commissioner Martin Makary
11:45 11:57 five questions for officials
11:57 12:25 31 questions from 22 different reporters for press secretary.
George Condon
The Office of Communications
Wed. Jan. 7, 12:33 PM
https://x.com/WHPressPool/status/2008655113062150574

White House Press Pool Reports @WHPressPool - In-town pool report #3 lunch lid
Lunch lid until 1:30 p.m.
George Condon
The Office of Communications
Wed. Jan. 7, 12:35 PM
https://x.com/WHPressPool/status/2008677274120273991

White House Press Pool Reports @WHPressPool - In-town pool report #4 - lid
The White House announced a travel/photo lid at 6:23.
George Condon
The Office of Communications
Wed. Jan. 7, 6:23 PM
https://x.com/WHPressPool/status/2008724995887833483

William Makis (McGill Medicine) @MakisMedicine - NEW RESEARCH: FENBENDAZOLE in CANCER - Inhibition of Cervical Cancer and Cervical Cancer Stem Cells, fantastic May 2025 Paper out of China!
Major new paper shows how Fenbendazole outperforms chemo!! 😃
HIGHLIGHTS:
Tests were done in vitro (test tubes) & in vivo (mice implanted with human tumors)
Goal was to see if Fenbendazole slows cancer growth, stops cells from dividing, kills cancer cells, and shrinks tumors, while also figuring out how it works
Key Findings from Lab Tests (In Vitro)
Cancer Stem Cells were isolated (1-3% of tumor cells) and were pulled out using markers on their surface (CD133 and CD44)
1. Fenbendazole slowed down growth in both Cervical Cancer Cells and Cervical Cancer Stem Cells with stronger effect at higher doses
2. Fenbendazole trapped cells in the “G2/M” stage of their life cycle, preventing division. Did it to both Cancer Cells and Cancer Stem Cells
3. Cell Death - FBZ triggered apoptosis of Cancer cells and Cancer Stem Cells
Key Findings from Animal Tests (In Vivo)
Setup: Female nude mice (with weak immune systems) got human HeLa cancer cells injected to grow tumors. Once tumors formed, mice were split into groups:
1. untreated,
2. low-dose FBZ (50 mg/kg),
3. high-dose FBZ (100 mg/kg),
4. or cisplatin (standard chemo) as a comparison.
Tumor Shrinkage:
High-dose Fenbendazole significantly slowed tumor growth over 23 days, reducing tumor volume and weight (about 53% inhibition).
Low-dose FBZ had milder effects (41% inhibition).
Cisplatin was stronger (75% inhibition) but caused bad side effects.
Safety:
Fenbendazole mice stayed healthy: no weight loss, normal behavior, eating, and no organ damage (heart, liver).
Cisplatin caused big weight loss and toxicity.
Survival:
Over 80 days, all untreated mice died.
Cisplatin saved 40% of mice.
Both Fenbendazole doses kept 100% of the mice alive (!!) (Commentary: This is absolutely wild)
 52